TIGIT and metastatic neoplasm: The majority of studies investigating TIGIT expression in TME across different malignancies have shown its negative impact on overall survival, progression-free survival, disease-free survival, recurrence-free survival, or its association with increased hazard for metastatic disease (Table 3).